Clark Estates Inc’s Medifast MED Stock Holding History

Clark Estates Inc’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,900	Closed	-$1.86M	–	97
2023 Q1	$1.86M	Sell	17,900 -4,000	-18%	-$443K	0.37%	82
2022 Q4	$2.53M	Hold	21,900	–	–	0.52%	70
2022 Q3	$2.37M	Hold	21,900	–	–	0.52%	70
2022 Q2	$3.95M	Buy	21,900 +7,200	+49%	+$1.29M	0.68%	43
2022 Q1	$2.51M	Buy	+14,700	New	+$2.77M	0.4%	80
2014 Q3	–	Sell	-45,000	Closed	-$1.37M	–	127
2014 Q2	$1.37M	Hold	45,000	–	–	0.2%	94
2014 Q1	$1.31M	Hold	45,000	–	–	0.2%	92
2013 Q4	$1.18M	Hold	45,000	–	–	0.17%	98
2013 Q3	$1.21M	Hold	45,000	–	–	0.18%	93
2013 Q2	$1.16M	Buy	+45,000	New	+$1.18M	0.2%	90

Other funds holding MED

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return